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A B S T R A C T   
Background: During the COVID-19 pandemic, antibody testing was proposed by several countries as a surveil-
lance tool to monitor the spread of the virus and potentially to ease restrictions. In the UK, antibody testing 
originally formed the third pillar of the UK Government’s COVID-19 testing programme and was thought to offer 
hope that those with a positive antibody test result could return to normal life. However, at that time scientists 
and the public had little understanding of the longevity of COVID-19 antibodies, and whether they provided 
immunity to reinfection or transmission of the virus. 
Objective: This paper explores the UK public’s understanding of COVID-19 testing, perceived test accuracy, the 
meaning of a positive test result, willingness to adhere to restrictive measures in response to an antibody test 
result and how they expect other people to respond. 
Methods: On-line synchronous focus groups were conducted in April/May 2020 during the first wave of the 
pandemic and the most stringent period of the COVID-19 restrictive measures. Data were analysed thematically. 
Results: There was confusion in responses as to whether those with a positive or negative test should return to 
work and which restrictive measures would apply to them or their household members. Participants raised 
concerns about the wider public response to positive antibody test results and the adverse behavioural effects. 
There were worries that antibody tests could create a divided society particularly if those with a positive test 
result were given greater freedoms or chose to disregard the restrictive measures. 
Conclusion: Should these tests be offered more widely, information should be developed in consultation with the 
public to ensure clarity and address uncertainty about test results and subsequent behaviours.   
1. Introduction 
At the end of December 2019, the World Health Organization (WHO) 
was alerted to a cluster of unusual pneumonia cases in Wuhan, Hubei 
Province in China. In early January 2020 this was identified as a novel 
SARS-CoV-2, subsequently known as COVID-19. Within a short space of 
time the virus had spread across the world and the WHO declared 
COVID-19 to be a pandemic (WHO 2020). 
In the first phase of the COVID-19 pandemic, antibody testing was 
proposed by several countries as a means of gathering data on the spread 
of the virus and/or, to inform strategies to ease restrictive measures, and 
test and trace programmes (Baraniuk 2020) particularly to identify the 
source of clusters of infections (Normile 2020). In the UK, the Prime 
Minister said antibody testing was a potential ‘game-changer’ (BBC 
2020). The presence of antibodies indicates an individual’s immune 
system has responded to the virus. Antibody tests differ from antigen 
tests that determine whether someone is currently infected. In the case 
of this virus, at the time this study was conducted in April/May 2020, 
scientists and the public had little understanding of the longevity of 
antibodies, and whether they provided immunity to reinfection or 
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transmission. The current (January 2021) knowledge is that antibodies 
are maintained for at least eight months (Dan 2021) and for at least three 
months in those who had mild COVID-19 symptoms (Rodda 2020). 
There is evidence that people can be re-infected (Parry 2020; Hall 2021) 
and work continues to gain a greater understanding of antibodies and 
immunity. Interim findings from a large cohort study of COVID-19 
antibody-positive and antibody-negative UK health workers found an-
tibodies, produced in response to a previous infection, provided 83% 
protection against reinfection for five months (Hall 2021). Although the 
findings have been welcomed, the sample consists primarily of women 
under the age of 60 and it is too early to determine immunity against the 
new variants of the virus (Ledford 2021). The cohort study will follow 
participants for 12 months to provide further data on how long immu-
nity lasts and the degree to which someone with immunity can transmit 
the virus to others (Hall 2021). 
In the UK, antibody testing originally formed the third pillar of the 
UK Government’s COVID-19 testing programme. They stated ‘Antibody 
tests offer the hope that people who think they have had the disease will 
know they are immune and get back to life as normal.’ (p. 4) (DHSC 
2020). The idea of antibody testing was explored by UK policymakers as 
a possible part of the strategy towards lifting various restrictions 
imposed in the first months of the pandemic (DHSC 2020). This study 
arises as a consequence of research conducted to support that policy 
exploration. 
Antibody testing has been debated in the scientific community 
(Armstrong 2020) and media. However, little is known about the UK 
public’s understanding of COVID-19 antibody testing and at the time of 
collecting the data for this study, there was no published literature on 
the topic. A study of the impact of antibody test terminology on perceived 
risk and behaviour concerning COVID-19, had found that the use of the 
term ‘immunity’ led to twice as many respondents perceiving they were 
at no risk of contracting COVID-19 as those who perceived a risk (Waller 
2020). They also found the terms ‘passport’, ‘certificate’ or ‘test’ did not 
affect perceived risk or anticipated behaviour. Perceived risk of con-
tracting SARS-CoV-2, developing COVID-19, and/or passing the virus to 
others is predictive of adherence to recommended behavioural 
pandemic control measures such as personal and environmental hy-
giene, use of face masks, social distancing, and self-isolation (Xie 2020). 
According to Protection Motivation Theory (PMT) (Rogers 1983), the 
intended response to a potential health threat is based on a threat 
appraisal, considering the perceived severity and susceptibility, and on a 
coping appraisal, considering the response efficacy and response cost of 
various responses, and the self-efficacy for these response options. PMT 
is the most frequently used theory of behaviour change in the context of 
infectious disease outbreaks and emergency responses (Weston 2020). 
From a PMT perspective, a positive antibody test could reduce the 
perceived susceptibility (and/or severity) and thus, undermine the 
motivation to adhere to pandemic control measures. Indeed, there is 
some evidence that people who believe they have had COVID-19 are less 
likely to be adherent (Smith 2020). 
The aim of our study, commissioned by the UK Department of Health 
and Social Care, was to explore using qualitative methods, public un-
derstanding of antibody testing more broadly beyond terminology. 
The study was conducted in the early months of what became the 
first period of lockdown in the UK. Data were collected between 29 April 
and May 8, 2020, when very stringent control measures to prevent social 
contacts were in force. The day before the first focus group, the national 
news had reported that the total number of COVID-19 deaths in the UK 
was just under 22,000, with 586 deaths (ITN News April 28, 2020). 
There had been an increase of 3996 people who tested positive since the 
previous day (GOV.UK 2020). This was the period just before one of the 
UK government’s first change of message. The alteration was from ‘Stay 
at home, Save lives, Protect the NHS’ to ‘Stay alert, control the virus, 
save lives’. At the time of the investigation, almost all schools were 
closed, and only the children of key workers were allowed to attend the 
few that remained open. Wherever possible the public were asked to 
work from home. The measures were, with the exception of key workers: 
to leave home only to shop for basic necessities, for a medical need or to 
help a vulnerable person, for one form of exercise each day; and, to keep 
a distance of 2 m from those not from the same household. Shops selling 
non-essential goods, restaurants and bars were closed. Numbers of 
mourners at funerals were restricted and social gatherings were banned. 
Those deemed clinically extremely vulnerable received a communica-
tion from the National Health Service to ask them to shield at home. This 
entailed avoiding all face-to-face contact and practicing social 
distancing with others in their household. The UK Government was 
working with partners to develop an antibody test with 98% accuracy 
for true positive and true negative cases. 
2. Methods 
2.1. Setting 
The study involved members of the public from England, Scotland, 
and Wales. 
2.2. Participants 
A purposive sampling strategy was used to include participants from 
a range of socio-economic and ethnic groups and of regions. Members 
were recruited from a market research company’s panel database. The 
company emailed panel members inviting those interested to complete a 
screening questionnaire. From those screened eligible, 60 members of 
the public were selected to ensure a mix of ages, homeownership, 
household type, ethnic group, employment status, socio-economic sta-
tus, and region. Twelve were invited to each group to ensure a minimum 
of eight participants. Consent to participate and to use quotations from 
the discussions in reports and publications was obtained by the 
company. 
3. Data collection procedures 
3.1. Design 
A qualitative design was chosen due to the exploratory nature of the 
research. Focus groups enabled the team to consider participants’ 
shared, or differences in, understanding as well as disagreements. In 
focus groups, the discussion is between participants and insights are 
gained from this interaction (Kitzinger, 1994). A further rationale and 
benefit of this method was the speed with which we were able to conduct 
the fieldwork. Not only was the landscape of the pandemic changing 
rapidly, but also the research needed to contribute to policy discussions 
at the time. Due to the COVID-19 restrictions on social contact, online 
focus groups on Zoom were used (Archibald 2019). The format of data 
generated from online and in-person focus groups may differ, but con-
tent generated by both is notably similar (Woodyatt 2016). The use of 
the panel database enabled heterogeneous groups and the online format 
the inclusion of participants from more remote UK regions. Participants 
were not known to each other or to the researchers before the session. 
3.2. Conduct of focus groups 
An open line of questioning was employed. The topics for each group 
were iterative, informed by the input of a steering committee of national 
policy stakeholders and from successive focus groups’ findings as they 
progressed. A member of the research team’s Patient and Public 
Involvement Strategy Group commented on the topic guide (Table 1). 
All focus groups were facilitated by a lead moderator (JL) and a second 
moderator. Towards the end of each session the latter were asked if there 
were any points they would like to clarify or explore, to pick up any 
issues the lead moderator may have overlooked. Extraction of themes 
and concepts was conducted initially by the moderators and reported to 
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a steering committee and wider team to inform the areas of exploration 
in the subsequent focus groups. Thematic saturation was deemed to have 
been met when new groups contributed no additional information or 
insights on the topics of interest. 
To gain insight into the public’s then understanding of COVID-19 
antibody testing, the sessions began with an open question to generate 
the group discussion. The moderator intervened only to introduce a new 
topic or if the discussion was straying into other non-relevant areas. 
Before the groups discussed the meaning of a positive test, participants 
were informed about the then scientific consensus. This was that a 
positive test meant a lower risk of reinfection and transmission of the 
virus. Test accuracy was explored in the groups based on the UK Med-
icines and Healthcare Products Regulatory Agency (MHRA) guidance on 
antibody testing for patients, the public and professionals (GOV.UK 
2020). In the MHRA’s Target Product Profile, the minimal requirements 
are that antibody self-tests have 98% clinical sensitivity (minimising 
false negatives) and 98% clinical specificity (minimising false positives) 
(GOV.UK 2020). For the first group 98% then 100% accuracy were 
discussed and for the second group this was reversed (100% then 98%) 
to determine whether the statement order had any impact. 
3.3. Analysis 
Group discussions were digitally recorded, transcribed, anonymised, 
and uploaded to NVivo 12 Pro (released March 2018) which was used 
for data management. A thematic analysis was undertaken (Braun and 
Clarke 2006) as described in Table 2. This was an inductive process, 
eliciting themes directly from the data. Other team members read 
through the transcripts independently to extract themes and concepts. 
These were compared with the rapid extraction conducted by the focus 
Table 1 
Topics covered in each focus group. 
Table 2 
Steps in data analysis.  
Step 1: Familiarisation with data – reading, re-reading and listening to recordings of 
interviews or focus groups. 
Step 2: Generate initial codes – systematically record features of the data that are 
interesting across the data. 
Step 3: Identify themes – coded extracts are sorted into overarching themes. 
Subthemes are developed where appropriate. 
Step 4: Review of themes – at this stage, themes are combined, refined, redefined or 
separated. From this map or framework is devised. 
Step 5: Defining and naming themes – another stage of refinement of the themes 
and sub-themes and the addition of concise working definitions of each theme.  
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group moderators and with the thematic framework. 
The exploration was not explicitly theoretically driven and we were 
not seeking to test a particular theory. We were instead interested to see 
what ideas the focus groups generated. PMT (Rogers 1983) served as a 
framework for the subsequent interpretation of the data because it fitted 
well with the themes that had emerged. PMT identifies two parallel 
processes, threat appraisal, and coping appraisal. These determine an 
individual’s intention to adopt, or not adopt, a protective behaviour. 
Threat appraisal is affected by how serious an individual believes the 
threat is to them and how vulnerable they are should the threat be 
realised, and the benefits of implementing a behaviour. Coping appraisal 
is determined by how effective an individual believes a behaviour will 
be in averting threat. The application of this framework helped to illu-
minate the participant responses to the uncertainties surrounding anti-
body testing. 
3.4. Ethical considerations 
The study received ethical approval from Newcastle University 
Research, Policy, Intelligence and Ethics Team, (Reference 2278/2020) 
on April 16, 2020. 
4. Results 
Five online focus groups were conducted between 29 April and May 
8, 2020. Details of the 59 focus group participants are given in 
Tables 3–4. All quotations have been anonymised to protect the identity 
of the participants. 
The overarching themes identified from the data were: the impact of 
scientific uncertainties about antibody testing; the pros and cons of 
antibody testing; and, response to and views of a positive and negative 
antibody test result. The sub-themes are discussed below within each 
theme. 
5. Uncertainties about antibody testing 
5.1. Accuracy of test results 
The accuracy of identifying the presence or absence of virus anti-
bodies with a test was explored. Statement order did not have any 
impact and most were satisfied with 98% predictive accuracy and said it 
provided ‘good odds’. A few pointed out that tests are rarely 100% ac-
curate. A small number in each of the two groups were concerned that 
the test was not 100% accurate. 
‘Yeah, 98% is good, but then if you’re incorrectly detected – so, they 
say that you have got the antibody when you haven’t and you then go 
out into the public and think ‘Oh great, I’ve had it’ or whatever, how 
many people are you then going to come into contact with before you 
then realise? You’re being less safe because you’ve been told you’ve got 
antibodies.’ Joyce – Group 3, 30, FT, Lives with Partner, White. 
‘Two people receiving the wrong result and being unaware of it is too 
much, in my opinion. Because then you can just go and infect so many 
people unknowingly because you had the confidence that ‘oh, I’m fine’. 
It takes just one person.’ Susan – Group 4,-26, FT, Lives with Parents, 
Mixed/Multiple ethnic group. 
In response to 98% accuracy and regardless of the test result, most 
said they would not drastically change their current behaviour and 
would continue to adhere to the restrictive measures which were then in 
force. This view was mostly attributable to a belief that these measures 
would be effective and to the uncertainties about antibody testing. 
5.2. Scientific uncertainties of reinfection and transmission with a positive 
test 
At the time of data collection, it was unknown whether someone who 
tested positive for antibodies could be re-infected or transmit the virus to 
others. In three of the five groups, these issues were raised spontane-
ously by participants early in the discussion, demonstrating an aware-
ness of these problems which at the time had received some media 
coverage. A positive test was presented to the groups, as a person being 
at a lower risk of re-infection and transmission. 
Uncertainty was a recurring theme. The absence of definitive scien-
tific knowledge about the virus and evidence about the meaning of a 
positive test in the scientific community, were raised as concerns by a 
number of participants. One respondent pointed out that the test could 
be ‘giving me a false sense of security that I’m not going to infect 
anybody else, when actually I could still be infectious’ (Jake - Group 1). 
Some questioned the benefit of testing considering the uncertainties for 
the individual. 
‘I just don’t think it’s the right question, it’s answering something 
that we don’t yet understand. So, before we spend an awful lot of time 
and energy and resources and everything else on doing antibody testing, 
what is it actually telling you? And until we know that, then I can see 
little point in doing it. The World Health Organization came out just a 
couple of days ago saying, just because you’ve had it, it doesn’t actually 
mean that you’re immune or that you can’t carry it. So until we’ve got a 
definitive answer to that, I can’t see a whole lot of point doing it.’ Paul – 
Group 1, 60, R, Lives with Partner, White. 
‘To have checked if you have got the antibodies against it is really 
good, but I’m just wondering if that’s going to be enough just to protect 
you. Because we’re not really sure whether that would work or not.’ 
Troy - Group 3, 52, FT, Lives with Partner/Children, Black. 
6. Pros and cons of antibody tests for COVID-19 
6.1. Perceived benefits of antibody testing to the individual and scientific 
community 
Antibody tests were considered by some group members to be of 
value to the individual and/or to the population and scientific com-
munity. Not all were interested in having an antibody test; for those who 
were, it was primarily to know if they had contracted the virus without 
suffering debilitating symptoms and the relief that they had not been 
hospitalised. The benefits for the wider population and scientific com-
munity, tests were thought by some participants to be that they were a 
useful surveillance tool and they provided valuable information on 
Table 3 
Participant details of the focus groups.  




Household Ethnic group 




Lives with Partner and 
Children 
White Black Asian Other 
G1 5 6 19–60 6 5 2 2 – 4 2 1 8 2 – 1 
G2 6 6 22–65 4 8 1 – 1 4 – 6 9 1 2 – 
G3 6 6 21–63 3 9 – 1 1 7 1 2 9 1 2 – 
G4 6 6 22–65 6 8 3 3 1 3 2 – 9 2 – 1 
G5 6 6 21–65 3 9 2 1 – 4 – 5 9 – 2 1  
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numbers infected per region or by communities, and on the longevity of 
antibodies. Increased understanding of COVID-19 was considered 
helpful in the development of a vaccine and to enable planning for lifting 
the restrictive measures. 
‘Just from a personal point, I would like the antibody test, I’d like my 
family to have the antibody test. But I think it will also give more 
background information to scientists and the medical profession, there 
might be some data comes out of it that would be helpful. So I’m in 
favour of it.’ June - Group 3, 66, R, Lives with Partner, White. 
‘But if there’s another wave of this, at least we have a history to go 
by, we can say ‘OK, this is what happens’ in the future, and we won’t 
have to be faffing around, trying to work out what to do. We will know 
what to do and it’s just about planning for the future really.’ Cheryl – 
Group 4, 40, SE, Lives with Parents, Black. 
Although the majority said antibody testing would be beneficial, 
there were a few dissenting voices. The feasibility of testing on a large 
scale and frequency of testing were questioned. It was considered by 
some to be a waste of resources that could be of greater use elsewhere, 
for example in the development of a vaccine. 
6.2. Potential societal divisions due to antibody testing 
Apart from the uncertainties for those with a positive test, another 
disadvantage of antibody testing was considered by some to be the po-
tential to create divisions in society at large. This was between both the 
tested and untested, and between those with a positive and negative test 
result. Most of the group discussion was related to the potential to 
impose distancing on individuals based on a negative test result. The 
tests, it was thought, could be divisive, particularly if those tested, or 
tested positive, had greater freedoms. 
‘If you have half of society who’ve had the antibody test and half who 
haven’t, is the other half of society treated differently? Can they go into 
shops? Can they not go into shops? And that’s a really big fundamental 
shift in how, I think, our societies work, …and now we’re turning 
around and potentially saying ‘well, society can do some things if you’ve 
had some tests or not’.’ Jake – Group 1, 43, SE, Partner and children, 
White. 
If those who tested negative were expected to continue to follow 
restrictive measures they would most likely consider this to be unfair, 
and it was suggested there may be a ‘bit of a clash’ (Nigel Group 4). One 
participant said they would feel ‘cross’ if others who had had the virus 
were given greater freedom, when they themselves had taken measures 
to avoid being infected (Jake Group 1). Another raised concerns about 
the psychological impact on those testing negative. A few said the sit-
uation would have to be carefully managed to ensure that those whose 
freedom continued to be restricted were not treated unfairly. 
‘I think it would affect people’s mental health ... Because if they’re 
stuck in for months and months and they think that other people are out, 
it could cause a problem.’ Eileen - Group 2, 65, R, Lives with Partner, 
White. 
‘It could create quite a divided society. (if) There are a group of 
people that get it first and everyone else has to stay in until they get that 
test. Whereas currently, a lot of us – unless you’re vulnerable – can still 
go to the shops, you can take measures, but there will still be a risk if 
you’ve had the test. I just think they’d have to do it carefully, because 
say you’re on social media watching a group of people out socialising 
and because you haven’t had this test, you’re still not able to do that.’ 
Maddie – Group 3, 21, FT, Lives with Parents, White. 
The potential implications for work and employment were raised in 
discussion and whether those with a negative test may be at a disad-
vantage if they were not allowed in the workplace. One said there could 
be a situation ‘with people being almost forced back to work’ (Thomas 
Group 5) if they have a positive test. Another raised the point that if a 
company had to make redundancies, those with a negative test – 
assuming there are issues with them returning to the workplace – could 
be at a greater risk. 
‘I think people might worry about their jobs if they tested negative, 
whether they would be at a disadvantage to colleagues who had tested 
positive, therefore are going to be needing to take time off work sick or 
self-isolate, etc, etc. I think it could affect people’s jobs adversely.’ Anita 
- Group 2, 49, SE, Lives with Partner, White. 
7. Views of a positive and negative antibody test result 
7.1. Individual response to a positive antibody test result 
Most group members perceived that a positive test result would 
provide a measure of reassurance and peace of mind. There were com-
ments about the comfort of having had a ‘mild form’ of the virus and 
getting ‘away with it quite lightly’ (Jeff Group 5). Those who were 
working outside the home said knowing they had had, or not had, the 
virus would alleviate the anxiety about infecting others in their house-
holds. In terms of risk perception, some participants talked about the 
reduced risk to others, rather than to themselves. A concern with 
infecting others and that a positive test would alleviate future anxiety 
and worry was primarily the view of female participants. 
‘I would be pleased too that I’d had it, so then I don’t have to worry 
now about infecting others or whatever, so I think it would bring a lot of 
relief to my – the stressful life at the moment. Because I don’t know 
whether I’ve had it in the past.’ Rasia - Group 2, 56, U, Lives with 
Partner/children, Asian. 
‘I don’t think I’d feel as guilty – because I go shopping once a week, 
but I do feel quite guilty for going shopping in case I am carrying it and 
I’m spreading it. So I think if I knew that I wasn’t able to spread it, I 
wouldn’t carry that guilt with me.’ Fiona - Group 4, 37, Lives with 
Children, White. 
Although the majority said they would welcome a positive test result, 
this was based on the assumption that the infection had short-term 
consequences. It did raise concerns for a few participants that they 
may have infected family members and anyone else with whom they 
may have come into contact, and the timescales of testing. 
‘Obviously, if I’ve tested for it … I’d be happy in that aspect, knowing 
Table 4 
Employment status and socio-economic group.   







Stay at home 
parent 
Unemployed Retired Student A B C1 C2 D E Urban Suburban Rural 
G1 4 3 2 – – 2 – 3 2 3 2 1 – 6 4 1 
G2 6  2 1 1 2 – 2 5 2 2 1 – 4 6 2 
G3 5 2 1 1 1 2 – 3 2 3 3 – 1 2 8 2 
G4 3 2 2 – 1 2 2 1 4 4 1 – 2 5 5 1 
G5 7 1 1 –  2 1 4 5 – 3 – – 4 6 2 
Note. Key to socio-economic groups: A-High managerial, administrative or professional; B-Intermediate managerial, administrative or professional; C1-Supervisory, 
clerical and junior managerial, administrative or professional; C2-Skilled manual workers; D-Semi and unskilled manual workers; E-State pensioners, casual or 
lowest grade workers, unemployed with state benefits only. Source: NRS 2008. 
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that I’ve kind of come through it. But then I’d be concerned about when I 
had it and who I’ve come into contact with, whether it be, obviously, my 
son or my elderly parents, … So who have I passed it to without 
knowing?’ Mike – Group 2, 34, FT, Lives with Partner/children, 
White. 
Participants were asked if they would change their behaviour in 
relation to the current measures (social distancing, restrictions on 
leaving home, hand hygiene) based on a positive test result. Only a 
minority discussed changing their behaviours and gave reasons. The first 
reason was to have direct contact with family members. 
‘But the first thing for me – and it’s kind of a selfish thing – I’ve got a 
number of conditions that put me at fairly high risk from it, so selfishly, I 
would love to know if I’ve already had it. And then, if indeed I have 
already had it, it’ll make it easier to probably interact with my kids and 
granddaughter.’ Paul – Group 1, 60, R, Lives with Partner, White. 
‘I’m quite low risk and don’t have any health conditions, so I’m not 
really too bothered to have a test, in a way. I think the only difference it 
would make for me is that I’d be able to go and see my grandma and feel 
a bit better about knowing that I’m not going to infect her.’ Kath – 
Group 1, 35, FT, Lives with Partner, White. 
The second reason was to relax measures for those shielding. One 
participant who had been shielding was more tentative about the idea of 
making any changes and questioned whether she would be able to leave 
her home if she had a positive test. The other said she probably would 
change her behaviour in light of a positive test. 
‘I’d be able to go out then, wouldn’t I? As it is, I don’t go out, my 
daughter does our shopping for us. We have a little walk, we’ve got quite 
a large garden we can walk around.’ Sharon - Group 4, 57, PT, Lives 
with Partner, White. 
‘Can I just say, for me, now I’m thinking about it, it would probably 
make a big difference, because I’m in the shielding group and if I know 
I’ve had it and I haven’t been too badly affected, etc, then I would just go 
to social distancing rather than full shielding. Because I haven’t been out 
of the house for weeks.’ Anita - Group 2, 49, SE, Lives with Partner, 
White. 
The third reason was to return to the workplace. One participant who 
wanted to return to work was staying at home as she had a cough and – 
confusing the antibody with the antigen test - said a positive test would 
help to distinguish between a normal cold and the COVID virus. She 
argued that a test would enable people to remain in the workplace. 
Another who was unable to work from home claimed they had experi-
enced financial difficulties and had had no support from elsewhere. 
They said they would be pleased with a positive test result and would 
return to work but also raised the issue of uncertainty of reinfection and 
transmission. 
‘Yeah, I’d be quite happy and, one, I’d have had it mildly and two, I’d 
probably go back to work, but we don’t know whether we can catch it 
twice or not […] I’m a taxi driver, so I’m going to have a one and a half 
metre-gap if you have them in the back, and you can wear masks, but 
what else can you do? You’ve still got to take people. … my only hope is, 
if I was tested that I’d had it and I’d had it in a mild form, I’d be very 
lucky and I’d hope that would make me more immune in the future and 
I’d go back to work.’ Clive - Group 2, 56, SE, Lives with Partner, 
White. 
Despite this desire to change their current behaviour they also 
expressed concerns about the fact that accuracy will not be 100% and, 
or, the uncertainties regarding a positive test. 
The majority said they would continue to follow the restrictive 
measures for a number of reasons. First, because of the uncertainties 
about testing and uncertainties about the virus. Second, some talked 
about the threat of the virus, a fear of contracting it or passing it to loved 
ones. A number had underlying health conditions or lived with others 
considered at high risk. Third, although acknowledging the adverse ef-
fects of restrictive measures on mental health, domestic violence and the 
economy, the view was to ‘ride out the storm’ and wait to see what 
happens. 
‘I’d probably stay to what I’m doing at the moment anyway, because 
I’m being quite cautious, not really going out, and just kind of getting on 
with everything at home. I have asthma, so I’m quite worried about 
getting it. If I had it already, then you can still get it, I’d still be quite 
concerned about that.’ Melissa - Group 5, 21, S, Lives with parents, 
White. 
‘I have an elderly mother at home who’s got quite a few underlying 
conditions and I’m just really terrified of leaving the house, because … I 
might bring it back and give it to her. So I just wouldn’t be happy 
socialising or being out there at all, because I’m scared for her.’ Jamilla 
– Group 3, 57, FT, Lives with Children, Asian. 
‘I feel like the way we’re going right now, we’ve been like six weeks 
in isolation and all these lockdown procedures. Why would you sabotage 
that now if what we’re doing seems to be working, to then go and change 
it and then have a second peak and everything’s for nothing? So I feel 
like it’s actually dangerous.’ Gail - Group 1, 26, FT, Lives with Chil-
dren, White. 
The majority of the participants had been able to work from home at 
least in the short term. With this in mind, most were not comfortable to 
return to the workplace whatever their test result. The view expressed in 
the first quotation below was representative of most participants. 
‘I’d want to be sure first that if I’ve had it, that I can no longer get it. 
And the people around me, before I take any risk, because that’s my 
worry at the moment, that people who may have had it, can you get it 
again or if I haven’t had it – stuff like that. So I’m quite worried about it 
coming back again if you’ve had it.’ Yvonne – Group 4, 49, FT, Lives 
with Children, Black. 
‘No, I would not go back to work, I would stay home, it’s too much of 
a risk to put yourself out there again. You can easily, easily get it. There’s 
no information that says you can’t get again. And I’ve read many stories 
about certain footballers who have contracted it more than once – I 
don’t know how true it is, but for myself, hearing that is not really good. 
So I’ll just keep myself to myself and stay home.’ Martin -Group 1–28, 
FT, Lives with Partner, Black. 
7.2. Individual response to a negative antibody test result 
Only a few participants were vocal about how they would respond to 
a negative test result. There was less discussion about responding to a 
negative than to a positive result. One participant said a negative result 
would only confirm what he already believed and because of the 
restrictive measures there was currently little value in being tested. 
‘We’re not going to be going to pubs in the next six months, …So 
there’s no urgency for me to know whether I’ve had it or not. And I’m 
90% sure – well, probably more that I haven’t had it, so just getting a test 
that says I haven’t had it is like ‘oh great, what’s that then?’ Freddie - 
Group 4, 22, Student, Lives with Friends, White. 
One participant commented that it would be proof that the measures 
they had taken were successful. Another said it would be a disappoint-
ment as he wanted to contract the virus and ‘get it out of the way (rather) 
than worry about it for the next however, 9–12 months’. 
‘If I tested negative, I’d be a bit gutted, obviously, because I’d hope 
I’ve had it already and not had any symptoms.’ Thomas – Group 5, 27, 
FT. Lives with Partner, White. 
In terms of changes to their behaviour based on a negative test result, 
one participant reported they would venture outside of their home more, 
knowing they were not a threat to others. Another participant mulled 
over the idea of relaxing their adherence to the restrictive measures, 
knowing they were negative, but raised concerns about the risk of 
becoming infected and passing the virus to family members. 
‘If I had a test at 98% saying that I had not got it, I’d feel safe going 
out and I would tell people I passed at 98%, then they could make their 
own decisions up.’ Andy – Group 3, 60, SE, Lives with Partner and 
Children. 
‘For me, even if I was negative, like I obviously want to go out and see 
my friends, but at the back of my head, I’m always like if I brought 
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something back to my family home – because I’m back at my parents’ at 
the moment – that would be where the risk is as well.’ Esther – Group 2, 
27, FT, Lives with Friends, White. 
The remainder said they would continue to adhere to the restrictive 
measures. Some added they would be more careful, by going outdoors 
less and finding alternative means to shop for essentials themselves. In 
contrast to the risk perception of a positive antibody test – being less of a 
risk to others - with a negative test most considered the risk was to 
themselves. 
‘At the moment I go shopping once a week, but I also take my chil-
dren for a walk every day, and I suppose if I’d got a negative antibody 
test back, then I would think twice about doing that.’ Fiona - Group 
4–37, Lives with Children, White. 
‘Even if you … didn’t have it, then you could catch it anyway, so you 
still have to social distancing and stay home and be safe.’ Patrick – 
Group 5, 58, FT, Live with partner, White. 
7.3. Perceptions of wider population response to antibody test results 
How the wider population might respond to a positive antibody test 
result was an emotive issue for some respondents. Although participants 
reported high personal motivation to adhere to restrictive measures 
regardless of antibody test results, there were major concerns that other 
people would not behave similarly. That others might return to pre- 
COVID-19 way of life and not adhere to the measures were mentioned 
in this regard. This was a particular problem in light of the uncertainties 
about reinfection and transmission of the virus in those with a positive 
antibody test result. 
‘The thing that concerns me is, as people have the test, are they going 
to sort of let their guard down and think ‘well, I’m OK. I don’t need to be 
doing this now’. … … so they’re less at risk, are they then going to just 
go out and ignore the guidelines?’ Ruth – Group 1–58, R, Lives with 
Partner, White. 
‘Especially people my age, I know for a fact will kind of see it as 
somewhat of a free pass to go immediately back to normality and forget 
everything that they’ve been following on social distancing, to be 
perfectly honestly with you.’ Richard – Group 3, 24, U, Lives with 
Friends, White. 
The view that other people would return to ‘old ways’ based on the 
antibody test appeared to be driven by witnessing others, albeit a mi-
nority, not adhering to the restrictive measures. One person commented 
that when given advice, ‘some people, they’ll only hear out of that what 
they want to hear and that’s a problem’ (Amy Group 5) and may ignore 
the uncertainties about a positive antibody test. Non-adherence to the 
measures was a key concern for most. Concerning a population response 
to a positive test, one person said, ‘I would feel even more nervous than I 
do now, because of lots of lunatics not complying’ (Paul Group 1). The 
implications were said to be undoing the good achieved through the 
measures and ‘being back where we started’ and the occurrence of a 
second wave. 
‘I’ve seen ignorant people out in the street that simply aren’t 
following the basic rules, so I couldn’t imagine, if they had a test, what 
they would be doing. …. The negative does outweigh the positive really, 
because we’ve sacrificed nearly seven weeks in isolation and to risk 
getting Britain moving again based on tests, it puts what everyone’s been 
doing at the minute at risk and I just don’t think it’s worth doing that. 
We’re doing OK at the minute, why risk that and ruin that and end up 
back at square one again? I just don’t think it’s worth it.’ Lisa Group 
1–30, FT, Lives Alone, Black. 
A few held the view that not everyone would stop adhering to the 
measures. One participant said behaviour will be moderated by fear of 
contracting the virus and by the uncertainty about what a positive 
antibody test means. Another said the response will depend on the in-
dividual’s circumstances rather than a lack of regard for the measures. 
‘Why would they be any different to the spread of opinion here? I 
think people aren’t really sure whether that … you’ve got antibodies is 
protective and means that you won’t spread it. I think if people knew 
that, absolutely, they probably would be willing to go back to virtually 
normal … But I don’t think we know those things yet.’ Louise – Group 5 
- -62, SE, Lives Alone, White. 
‘If, economically, you’ve got to get out there to work to start paying 
the bills again, then your views are very different to someone who can 
work from home … So I think it just depends on circumstances, to what 
risks you’re prepared to take.’ Jonathan - Group 5, 47, FT, Lives with 
Partner/children, White. 
Concerns were raised about the risks to those with a negative anti-
body test. One participant commented that those who tested positive 
may not understand ‘they’re still a potential carrier and a potential risk’ 
and get too close to others (Nigel - Group 4). A few mentioned the 
potential for people to copy the behaviour of others. A scenario was 
suggested in which the actions of those tested positive, such as relaxing 
the current measures, may result in conflict or mimicking the behav-
iours. This led to questions about the whole point of antibody testing. 
‘I don’t see the benefit of it because if ... I’ve already had it, I’ll just 
walk closer to somebody – you’re giving off bad habits and people start 
either getting the hump with you or copying you. Then it just becomes a 
bit unruly and then everyone will think ‘well … ’ and it just sort of falls 
down. I think it all needs to play by the same rules until we get more 
under control … It’s too much uncertainty there, I think. Thomas – 
Group 5, 27, FT. Lives with Partner, White. 
If the measures were relaxed for those with a positive antibody test, 
the issue was raised as to whether those tested negative may try to 
become infected. Views on this were mixed: some said it was a possi-
bility and others that they could not believe anyone would take such a 
risk. 
7.4. Understanding of the meaning of a negative or positive antibody test 
One potential perceived benefit of antibody testing mentioned by 
participants was the relaxation of restrictive measures. During the dis-
cussions, it transpired that there were different understandings as to 
whether those with a negative or a positive result would return to their 
workplace. Most appeared to assume that it would be those who test 
positive who would return to workplaces but there were alternative 
views. 
‘For the ones that are at home, self-isolating, if they’ve not – well, say 
that they’re self-isolating because they’ve got symptoms and they were 
negative, then yes, they’d be probably more inclined to come to work. 
Because they don’t feel like they’ve got something they could pass onto 
their team or the customers.’ Joyce – Group 3–30, FT, Lives with 
Partner, White. 
Discussion about teachers being part of an antibody testing pro-
gramme highlighted perceptions of risks to teachers and their families 
rather than to the pupils. If teachers who tested negative returned, one 
participant pointed out there would be a need for repeat testing. The 
second quotation illustrates this participant’s lack of recognition of the 
uncertainties about the risk of reinfection and transmission with a pos-
itive antibody test. 
‘If the schools do go back and you’ve got a class full of 30 kids, the 
likelihood is that it’s going to transmit to (teachers) at some point. So it 
goes back to that point the gentleman made … about how many times 
they have the test, how regularly. So I see it as a bit pointless really.’ 
Dave - Group 2–52, FT, Lives with Partner/children, White. 
‘If a teacher knows that they’ve had it because they’ve had the 
antibody test, they can go into school and teach the key workers’ chil-
dren rather than teachers who are currently just doing like a rota of who 
goes in on which days. They can prioritise the people that they know 
have had that so they’re not going to catch it and take it back home to 
their families. So I imagine, if you’re a teacher, you’re quite worried 
about teaching key workers’ children, simply because of the risk of the 
infection from them.’ Anita - Group 2–49, SE, Lives with Partner, 
White. 
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Although not frequently observed in the group discussions, there 
were some comments that suggested confusion about positive or nega-
tive antibody test results in terms of which is the better of the two. 
Irene: ‘If I had 98% test, I’d feel very secure in going out and 
socialising again.’ 
Facilitator 1: ‘Is that if you tested positive or negative?’ 
Irene: ‘If I passed, you know, if I passed in a good way.’ 
Irene – Group 3, 46, FT, Lives with Partner. 
‘If you are all high risk and classed to spread the virus on, you’re 
more likely to stay home than to go to your parents’ house or grand-
mother’s house and pass on the disease to them. So if I had information 
that I’m high risk, I probably would stay to myself until there’s a cure 
out there.’ Martin – Group 1, 28, FT, Lives with Partner. 
8. Discussion 
This qualitative study highlights the confusion amongst some 
members of the UK public in the early stages of the pandemic about the 
different tests for COVID-19, worries over the uncertainties in the sci-
entific community regarding reinfection and transmission for those with 
a positive test, the meaning of positive and negative test results for 
future behaviour with regard to the restrictive measures and the po-
tential inequities these tests could create. 
The findings of this study are congruent with Protection Motivation 
Theory (PMT), which states that protection motivation, or the intention 
to adopt protective behaviours is a function of a threat appraisal, 
considering severity and vulnerability of a potential health threat, a 
coping appraisal of the efficacy and costs of potential responses, and the 
self-efficacy to execute them (Rogers 1983). From an individual 
perspective, positive antibody tests were seen to affect threat appraisal 
through lowered perceptions of susceptibility. Participants highlighted 
that unknowns about antibody testing affected their ability to evaluate 
the nature of the threats about infection, reinfection and transmission 
with and without antibodies. Whilst they considered others to become 
less likely to adhere to protective measures after a positive antibody test, 
many did not expect a positive antibody test to affect their own 
behaviour, arguably due to the lack of certainty. This was also due to 
their coping appraisal. Participants held strong beliefs, at the time of the 
fieldwork, that the restrictive measures would protect participants and 
their families and there was a high level of reported self-efficacy and 
adherence to those measures that were in operation at that time. 
From a collective perspective in the Spring of 2020, antibody testing 
was discussed in the context of its effectiveness as a potential strategy to 
manage the pandemic by excluding those with a positive antibody test 
from restrictive protective measures. Participants were unconvinced 
that this would be an efficient response due to uncertainties about test 
accuracy and immunity effects and fear of being infected or infecting 
others. This was especially the case as a number of participants were in 
the higher risk group (had co-morbid conditions or were key workers). 
Social distancing and personal protective behaviours were viewed as the 
more efficient response and one that participants had confidence in, in 
spite of its cost to personal, social and economic life. 
The focus groups highlighted the significance of uncertainties about 
antibody testing as a new threat. Uncertainties about the test had to be 
evaluated in addition to threats from the virus. There is a risk that the 
overall levels of uncertainty about the meaning and implications of a 
positive or negative antibody test will produce raised levels of anxiety 
without adaptive behaviour (Lazarus 1980). In consideration of the 
wider public response to a positive test, the majority view in this study 
was that it would lead to a large proportion of the population ignoring 
the restrictive measures. A widespread reduction in adherence to the 
measures could impact on social norms and lead to those with a negative 
antibody test copying behaviours of those with a positive antibody test 
assuming their immunity. This was considered a danger to everyone and 
impacted on their threat appraisal. Where the nature of the threat is 
uncertain, as here, it is not surprising that participants varied in the 
responses that they said themselves and others would make. It is not 
clear how stable these views were and when the fieldwork was con-
ducted, neither we nor the respondents had any sense of the restrictions 
continuing beyond the end of 2020. 
Other key findings were that with a negative test, some participants 
considered themselves to be at greater risk, and they would be more 
careful and go out less. The data show a danger that testing could result 
in some members of the public who had a negative test being anxious 
about changing their behaviour anyway when control measures were 
relaxed. This highlights that if a testing programme were to proceed, 
there would be a need to advise the public about protective behaviours 
for both positive and negative test results. Another downside to 
population-wide antibody testing revealed in this investigation was the 
potential for inequities. A society composed with one group who have a 
positive test result and another a negative test result (or not tested) was 
thought to be potentially divisive and setting a worrying precedent, 
particularly if the former have greater freedoms. Concerns were raised 
about the potential for workplace discrimination. It was feared that test 
results could be used by employers to dictate who can return and who is 
retained if there were a need to reduce staff numbers. These concerns 
have been raised by others (Kofler 2020; Nuffield 2020) who also argue 
that more affluent people will be able to purchase an antibody test, 
further discriminating against poor, marginalised and vulnerable groups 
(Kofler 2020). The potential implication is a situation where the wealthy 
enjoy greater freedoms, which could be beneficial from both a psycho-
logical and economic perspective. Sociologists have coined the term 
biocitizenship to refer to differences in citizenship rights rooted in bio-
logical states (Rose 2005). There are concerns that immunity could be 
one such biological state used to determine personal freedoms and 
concerns about the inequalities that could then arise. There are histor-
ical parallels with immunity to yellow fever being associated with ra-
cialized injustice in 19th century USA (Brown 2020). 
When we embarked upon this research, COVID-19 antibody testing 
was a hotly debated topic and was thought to be a viable policy option. 
However, it has proven to be a more difficult strategy to bring to bear on 
the pandemic than was originally assumed. The reasons include un-
certainties about immunity and the lifespan of antibodies, and the 
technical and logistical aspects of testing. In addition to these issues our 
study has shown that in terms of public attitudes and beliefs, antibody 
testing as part of a COVID-19 strategy is very complex and not a simple 
game-changer. 
At the time of finalising this article, in the period since the data were 
gathered, the UK Government has not followed through with national 
policies about public antibody testing. There has been a further wave of 
infection starting towards the end of 2020, new mutations of the virus 
have appeared and death rates per day are higher in January 2021 than 
at the time the fieldwork was originally conducted. The UK is once again 
in a form of almost total lockdown and the basic message from gov-
ernment is to stay home and as far as possible keep away from others. In 
the UK a rollout of vaccines has begun, and it may be that the possibility 
of immunity through this route, will have crystalized people’s thinking 
about antibody testing, or rendered the whole approach redundant. 
However, based on current early research findings (Hay, 2021) it has 
been reported in journals and the media that natural immunity from 
infection could offer more protection than some of the vaccines (Ledford 
2021; Sample 2021). With antibody tests readily available to purchase 
online and through local pharmacies, members of the public who are 
unsure about being vaccinated – or do not want to wait until they are 
offered one – may resort to having these tests before immunity is fully 
understood. The concerns raised by those in the focus groups of wide-
spread reduction in adherence to the measures based on a positive test 
could be realised. 
But should antibody testing be adopted we would argue an infor-
mation campaign, designed in collaboration with the members of the 
public, would be required. Test accuracy would need to be carefully 
framed with guidance on protective behaviours to reassure those who 
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are anxious about less than 100% accuracy. The uncertainties would 
need to be fully explained and guidance on protective behaviours for 
both positive and negative test results provided. Format and modes of 
delivery of this campaign would also need to be explored in collabora-
tion with members of the public. 
8.1. Policy implications 
There are several implications for policies on antibody testing. If 
these tests should form part of a COVID-19 policy pathway there are four 
key points to consider. First, there is a need to address the uncertainties 
about the meaning of a positive antibody test result and manage ex-
pectations about the perceived individual benefits of testing. Second, 
there is a danger that those with a positive test result will assume they 
are safe and disregard protective measures which could lead to a general 
undermining of population adherence to restrictions. Without reducing 
uncertainty about immunity, it is questionable whether messaging will 
affect this potential public response. Third, there is also a risk of 
elevating general levels of anxiety resulting in a reluctance to follow less 
stringent government restrictive measures, and a potentially detrimental 
impact on mental health. Finally, there is the danger of exacerbating 
social divisions through these tests, particularly between those who 
could or could not afford to purchase an antibody test, and this must be 
avoided or carefully managed. Inter alia these points also perhaps speak 
to framing any campaigns about vaccination. 
8.2. Strengths and limitations 
This was a qualitative study and therefore the views of those who 
participated may not be representative of the wider UK population. The 
study was conducted at a particular moment in the pandemic. The death 
toll is now very much higher than was probably anticipated in the Spring 
of 2020 when the fieldwork was done. Vaccines are now available, but 
new variants of the virus have appeared and they seem to be much more 
transmissible than during the initial phases. It is difficult to judge 
without further empirical investigation how much attitudes may have 
changed or remained stable. It was also not possible to explore whether 
participants expressed views were consistent with their behaviour. The 
need to conduct online focus groups enabled the inclusion of individuals 
from different regions across the UK, something that would have been 
difficult logistically with face-to-face focus groups. Group participants 
could compare and discuss regional differences particularly concerning 
adherence to the restrictive measures. One limitation of this mode of 
data collection is that those without internet access were excluded. 
The focus groups provided a window on the discussions between 
members of the public, and through this, valuable insights into their 
understanding about antibody testing at a specific point in time. Clearly, 
this method does not allow for an in-depth exploration of the views of 
individuals, but this study had no aim to do so. We found a higher level 
of self-reported adherence with the restrictive measures than in 
contemporary quantitative studies (Smith 2020). It may be that our 
study attracted those who were more anxious about being infected, and 
hence were more compliant with the restrictive measures. Another 
explanation for the high level of reported adherence could be that the 
online ‘face-to-face’ focus group format introduced social desirability 
bias. New research has been published since our fieldwork, specifically 
about the lifespan of antibodies, and it seems likely that more will be 
learned about immunity in due course. 
9. Conclusions 
There is a wealth of information and misinformation that the public 
can access about the pandemic. Some aspects are technical and difficult 
for non-specialists to understand, and sometimes they are contradictory. 
Nonetheless, if in the future antibody tests can offer the promise, or be 
part of a return to usual activities, any information developed to assist 
their implementation must clearly communicate: What the test measures 
and how it differs from the test that determines if the person is currently 
infected with the virus; test accuracy; uncertainty about re-infection and 
transmission following a positive test result; and guidance on appro-
priate and safe behaviours for both test outcomes. There is a clear risk 
that those tested positive may be less adherent to social distancing 
measures and in doing so, add risk and shift the social norm for others. 
To ensure clarity, information should be developed in collaboration with 
members of the public. The findings provide a starting point for com-
munications with the general public about antibody testing. 
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